FDA Approved Treatments

Our goal is to help cancer patients understand immunologic drug therapies. We have summarized the most common areas of the body where cancers are found and the approved medicines below.

There are many types of cancer and scientists are constantly creating new immunologic treatments* that are giving patients a better opportunity for a cure. We have also included some internationally available treatments, not yet approved in the USA, in our searchable Success Stories.

As well, many USA clinical trials are underway that combine the medicines below with other experimental medicines to create a new immunological treatment. Clinical trials are complicated to research; however, a current list of National Cancer Institute Supported Cancer Trials can be found at Cancer.gov

The purpose of listing these approved medicines is so cancer patients, or an advocate, can ask their oncologist if these medicines are being considered in their treatment.  Keep up to date on newly approved treatments – Subscribe to our free Patient Newsletter.

 

Types of Cancer Drug Name Brand Name
Acute Lymphoblastic Leukemia (ALL) Inotuzumab ozogamicin Besponsa
Acute Lymphoblastic Leukemia (ALL) Pediatric Tisagenlecleucel (Gene Therapy) Kymriah
Acute Myeloid leukemia Enasidenib IDHIFA
Bladder Atezolizumab Tecentriq®
Nivolumab Opdivo®
Blood cancer (eGVHD related) Ibrutinib Imbruvica
Brain Bevacizumab Avistan® (for adults),
Dinutuximab Unituxin® (for children)
Breast Trastuzumab Herceptin®
Pertuzumab Perjeta®
Ado Trastuzumab Emtanzine Kadcyla®
Cervical Bevacizumab Avistan®
Colorectal Bevacizumab Avistan®
Cetuximab Erbitux®
Ramucirumab Cyramza®
Panitumumab Vectibix®
Epithelial ovarian, fallopian tube, peritoneal Olaparib Lynparza, AstraZeneca
Esophageal Trastuzumab Herceptin®
Ramucirumab Cyramza®
Head and neck Nivolumab Opdivo®
Pembrolizumab Keytruda®
Cetuximab Erbitux®
Kidney/Renal Nivolumab Opdivo®
Leukemia Blinatumomab Blincyto®
Leukemia AML (t-AML) or AML w/ AML-MRC Daunorubicin/cytarabine Vyxeos
Liver – Hepatocellular Nivolumab Opdivo
Lung Bevacizumab Avistan®
Ramucirumab Cyramza®
Atezlizumab Tecentriq®
Dabrafenib Tafinlar®
Trametinib Mekinist®
Lymphoma Rituximab Avistan®
Hyaluronidase
Non-Hodgkin Lymphoma (Aggressive Large B-cell) Axicabtagene Ciloleucel Yeskarta
Melanoma Ipilimumab Yervoy®
Pembrolizumab Keytruda®
T-VEC Imlygic ®
Aldesleukin Proleukin®
Interferon Alfa-2b Intron A®
Peginterferon Alfa-2b PEG-Intron or Sylatron®
Multiple Myeloma Daratumumab Darzalex®
Elotuzumab Empliciti®
Ovarian Bevacizumab Avistan®
Prostate Sipuleucel-T Provenge ®
Sarcoma Denosumab Xgeva ®
Stomach Trastuzumab Herceptin®
  • Medical professionals use scientific terms to be more specific about treatments. Some of these terms include: Cytokines, vaccines, antibodies, checkpoint inhibitors, customized cell based therapies and immune modulators.

**  This is an ongoing list and may not be a complete listing. New FDA approvals will be added as they become available.